{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:39:03Z","timestamp":1790300343192,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01317-4","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T12:33:13Z","timestamp":1766838793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association between mental health and MASLD molecular insights through metabolomics"],"prefix":"10.1038","volume":"6","author":[{"given":"Dashuai","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1491-2591","authenticated-orcid":false,"given":"Shouxin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3309-1133","authenticated-orcid":false,"given":"Xian","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6452-9355","authenticated-orcid":false,"given":"Wenzhi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,27]]},"reference":[{"key":"1317_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani, S. K., Devarbhavi, H., Eaton, J. & Kamath, P. S. Burden of liver diseases in the world. J. Hepatol. 70, 151\u2013171 (2019).","journal-title":"J. Hepatol."},{"key":"1317_CR2","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"key":"1317_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang, D. Q., El-Serag, H. B. & Loomba, R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 18, 223\u2013238 (2021).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1317_CR4","first-page":"459","volume":"46","author":"S Driessen","year":"2023","unstructured":"Driessen, S. et al. Metabolic dysfunction-associated steatotic liver disease and the heart. Hepatology 46, 459\u2013473 (2023).","journal-title":"Hepatology"},{"key":"1317_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111891","volume":"217","author":"R Mollace","year":"2024","unstructured":"Mollace, R. et al. Role of MASLD in CVD: a review of emerging treatment options. Diab. Res Clin. Pr. 217, 111891 (2024).","journal-title":"Diab. Res Clin. Pr."},{"key":"1317_CR6","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes. Clin. Gastroenterol. Hepatol. 22, 1999\u20132010.e8 (2024).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"1317_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","volume":"73","author":"G Targher","year":"2024","unstructured":"Targher, G., Byrne, C. D. & Tilg, H. MASLD: a systemic metabolic disorder with cardiovascular and malignant complications. Gut 73, 691\u2013702 (2024).","journal-title":"Gut"},{"key":"1317_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.14309\/ajg.0000000000003215","volume":"120","author":"N Shah","year":"2025","unstructured":"Shah, N. & Sanyal, A. J. A pragmatic management approach for metabolic dysfunction-associated steatosis and steatohepatitis. Am. J. Gastroenterol. 120, 75\u201382 (2025).","journal-title":"Am. J. Gastroenterol."},{"key":"1317_CR9","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/oby.22964","volume":"28","author":"MP Moore","year":"2020","unstructured":"Moore, M. P., Cunningham, R. P., Dashek, R. J., Mucinski, J. M. & Rector, R. S. A fad too far? dietary strategies for the prevention and treatment of NAFLD. Obesity 28, 1843\u20131852 (2020).","journal-title":"Obesity"},{"key":"1317_CR10","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/TP.0b013e31820b6b84","volume":"91","author":"P Dureja","year":"2011","unstructured":"Dureja, P. et al. NAFLD recurrence in liver transplant recipients. Transplantation 91, 684\u2013689 (2011).","journal-title":"Transplantation"},{"key":"1317_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-023-02941-x","volume":"23","author":"E Asquith","year":"2023","unstructured":"Asquith, E., Bould, K., Catling, J. C., Day, E. J. & Holt, A. Behaviour regulation and the role of mental health in non-alcoholic fatty liver disease. BMC Gastroenterol. 23, 306 (2023).","journal-title":"BMC Gastroenterol."},{"key":"1317_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2446390","volume":"17","author":"SC Harris","year":"2025","unstructured":"Harris, S. C. & Bajaj, J. S. Interaction of the gut-liver-brain axis and the sterolbiome with sexual dysfunction in patients with cirrhosis. Gut Microbes 17, 2446390 (2025).","journal-title":"Gut Microbes"},{"key":"1317_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-020-2425-3","volume":"585","author":"T Teratani","year":"2020","unstructured":"Teratani, T. et al. The liver-brain-gut neural arc maintains the T(reg) cell niche in the gut. Nature 585, 591\u2013596 (2020).","journal-title":"Nature"},{"key":"1317_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2020.05.054","volume":"182","author":"H Qing","year":"2020","unstructured":"Qing, H. et al. Origin and function of stress-induced IL-6 in murine models. Cell 182, 372\u2013387.e14 (2020).","journal-title":"Cell"},{"key":"1317_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2024.101185","volume":"6","author":"F Carli","year":"2024","unstructured":"Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A. & Gastaldelli, A. Lipid metabolism in MASLD and MASH: from mechanism to the clinic. JHEP Rep. 6, 101185 (2024).","journal-title":"JHEP Rep."},{"key":"1317_CR16","doi-asserted-by":"crossref","unstructured":"Do, A., Zahrawi, F. & Mehal, WZ. Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH). Nat. Rev. Drug. Discov. 24, 171\u2013189 (2024).","DOI":"10.1038\/s41573-024-01084-2"},{"key":"1317_CR17","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/eurheartj\/ehaa209","volume":"41","author":"J Li","year":"2020","unstructured":"Li, J. et al. The Mediterranean diet, plasma metabolome, and cardiovascular disease risk. Eur. Heart J. 41, 2645\u20132656 (2020).","journal-title":"Eur. Heart J."},{"key":"1317_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2023.101238","volume":"91","author":"G Musso","year":"2023","unstructured":"Musso, G., Saba, F., Cassader, M. & Gambino, R. Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): recent advances. Prog. Lipid Res. 91, 101238 (2023).","journal-title":"Prog. Lipid Res."},{"key":"1317_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102971","volume":"79","author":"R Xie","year":"2025","unstructured":"Xie, R. et al. Novel type 2 diabetes prediction score based on traditional risk factors and circulating metabolites: model derivation and validation in two large cohort studies. EClinicalMedicine 79, 102971 (2025).","journal-title":"EClinicalMedicine"},{"key":"1317_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12933-025-02581-3","volume":"24","author":"R Xie","year":"2025","unstructured":"Xie, R. et al. Improving 10-year cardiovascular risk prediction in patients with type 2 diabetes with metabolomics. Cardiovasc. Diabetol. 24, 18 (2025).","journal-title":"Cardiovasc. Diabetol."},{"key":"1317_CR21","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.ophtha.2024.07.004","volume":"131","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multinational cohorts. Ophthalmology 131, 1436\u20131446 (2024).","journal-title":"Ophthalmology"},{"key":"1317_CR22","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell, E. E., Wong, V. W. & Rinella, M. Non-alcoholic fatty liver disease. Lancet 397, 2212\u20132224 (2021).","journal-title":"Lancet"},{"key":"1317_CR23","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","volume":"184","author":"R Loomba","year":"2021","unstructured":"Loomba, R., Friedman, S. L. & Shulman, G. I. Mechanisms and disease consequences of nonalcoholic fatty liver disease. Cell 184, 2537\u20132564 (2021).","journal-title":"Cell"},{"key":"1317_CR24","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.jhep.2017.06.003","volume":"67","author":"JG Fan","year":"2017","unstructured":"Fan, J. G., Kim, S. U. & Wong, V. W. New trends on obesity and NAFLD in Asia. J. Hepatol. 67, 862\u2013873 (2017).","journal-title":"J. Hepatol."},{"key":"1317_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3350\/cmh.2023.0485","volume":"30","author":"MH Le","year":"2024","unstructured":"Le, M. H. et al. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Clin. Mol. Hepatol. 30, 235\u2013246 (2024).","journal-title":"Clin. Mol. Hepatol."},{"key":"1317_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11524-020-00498-8","volume":"98","author":"Z Ni","year":"2021","unstructured":"Ni, Z. et al. Response to the COVID-19 Outbreak in Urban Settings in China. J. Urban Health 98, 41\u201352 (2021).","journal-title":"J. Urban Health"},{"key":"1317_CR27","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S2215-0366(20)30307-2","volume":"7","author":"C Moreno","year":"2020","unstructured":"Moreno, C. et al. How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry 7, 813\u2013824 (2020).","journal-title":"Lancet Psychiatry"},{"key":"1317_CR28","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S2215-0366(16)30219-X","volume":"4","author":"D Giacco","year":"2017","unstructured":"Giacco, D. et al. Scenarios for the future of mental health care: a social perspective. Lancet Psychiatry 4, 257\u2013260 (2017).","journal-title":"Lancet Psychiatry"},{"key":"1317_CR29","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s11920-023-01426-8","volume":"25","author":"M Moitra","year":"2023","unstructured":"Moitra, M. et al. Global mental health: where we are and where we are going. Curr. Psychiatry Rep. 25, 301\u2013311 (2023).","journal-title":"Curr. Psychiatry Rep."},{"key":"1317_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.934113","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang, Q. et al. Gut microbiota-mitochondrial inter-talk in non-alcoholic fatty liver disease. Front. Nutr. 9, 934113 (2022).","journal-title":"Front. Nutr."},{"key":"1317_CR31","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1021\/acs.jafc.1c00751","volume":"69","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Dietary polyphenols to combat nonalcoholic fatty liver disease via the gut-brain-liver axis: a review of possible mechanisms. J. Agric Food Chem. 69, 3585\u20133600 (2021).","journal-title":"J. Agric Food Chem."},{"key":"1317_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jhep.2021.11.008","volume":"76","author":"VT Kronsten","year":"2022","unstructured":"Kronsten, V. T., Tranah, T. H., Pariante, C. & Shawcross, D. L. Gut-derived systemic inflammation as a driver of depression in chronic liver disease. J. Hepatol. 76, 665\u2013680 (2022).","journal-title":"J. Hepatol."},{"key":"1317_CR33","doi-asserted-by":"crossref","unstructured":"Wang, SZ., Yu, YJ., Adeli, K. Role of gut microbiota in neuroendocrine regulation of carbohydrate and lipid metabolism via the microbiota-gut-brain-liver axis. Microorganisms 8, 527 (2020).","DOI":"10.3390\/microorganisms8040527"},{"key":"1317_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-024-03122-4","volume":"14","author":"S Malan-M\u00fcller","year":"2024","unstructured":"Malan-M\u00fcller, S. et al. Probing the oral-brain connection: oral microbiome patterns in a large community cohort with anxiety, depression, and trauma symptoms, and periodontal outcomes. Transl. Psychiatry 14, 419 (2024).","journal-title":"Transl. Psychiatry"},{"key":"1317_CR35","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2162306","volume":"15","author":"S Malan-M\u00fcller","year":"2023","unstructured":"Malan-M\u00fcller, S., Valles-Colomer, M., Palomo, T. & Leza, J. C. The gut-microbiota-brain axis in a Spanish population in the aftermath of the COVID-19 pandemic: microbiota composition linked to anxiety, trauma, and depression profiles. Gut Microbes 15, 2162306 (2023).","journal-title":"Gut Microbes"},{"key":"1317_CR36","doi-asserted-by":"publisher","first-page":"j5145","DOI":"10.1136\/bmj.j5145","volume":"360","author":"JC Clemente","year":"2018","unstructured":"Clemente, J. C., Manasson, J. & Scher, J. U. The role of the gut microbiome in systemic inflammatory disease. BMJ 360, j5145 (2018).","journal-title":"BMJ"},{"key":"1317_CR37","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jhep.2020.05.047","volume":"73","author":"RP Rai","year":"2020","unstructured":"Rai, R. P. et al. Blocking integrin \u03b1(4)\u03b2(7)-mediated CD4 T cell recruitment to the intestine and liver protects mice from western diet-induced non-alcoholic steatohepatitis. J. Hepatol. 73, 1013\u20131022 (2020).","journal-title":"J. Hepatol."},{"key":"1317_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.167395","volume":"906","author":"J Luo","year":"2024","unstructured":"Luo, J. et al. Exposure to low-intensity noise exacerbates nonalcoholic fatty liver disease by activating hypothalamus pituitary adrenal axis. Sci. Total Environ. 906, 167395 (2024).","journal-title":"Sci. Total Environ."},{"key":"1317_CR39","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/mp.2016.44","volume":"21","author":"P Zheng","year":"2016","unstructured":"Zheng, P. et al. Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host\u2019s metabolism. Mol. Psychiatry 21, 786\u2013796 (2016).","journal-title":"Mol. Psychiatry"},{"key":"1317_CR40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","volume":"13","author":"C Leung","year":"2016","unstructured":"Leung, C., Rivera, L., Furness, J. B. & Angus, P. W. The role of the gut microbiota in NAFLD. Nat. Rev. Gastroenterol. Hepatol. 13, 412\u2013425 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1317_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1317_CR42","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s13238-017-0436-0","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang, X., Ji, X., Wang, Q. & Li, J. Z. New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Protein Cell 9, 164\u2013177 (2018).","journal-title":"Protein Cell"},{"key":"1317_CR43","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1039\/C7FO01528C","volume":"9","author":"A Mancini","year":"2018","unstructured":"Mancini, A., Campagna, F., Amodio, P. & Tuohy, K. M. Gut:\u2009liver:\u2009brain axis: the microbial challenge in the hepatic encephalopathy. Food Funct. 9, 1373\u20131388 (2018).","journal-title":"Food Funct."},{"key":"1317_CR44","doi-asserted-by":"crossref","unstructured":"Milosevic, I. et al. Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature. Int. J. Mol. Sci. 20, 395 (2019).","DOI":"10.3390\/ijms20020395"},{"key":"1317_CR45","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.cmet.2024.03.011","volume":"36","author":"MA Tincopa","year":"2024","unstructured":"Tincopa, M. A., Anstee, Q. M. & Loomba, R. New and emerging treatments for metabolic dysfunction-associated steatohepatitis. Cell Metab. 36, 912\u2013926 (2024).","journal-title":"Cell Metab."},{"key":"1317_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155983","volume":"159","author":"D Arold","year":"2024","unstructured":"Arold, D., Bornstein, S. R., Perakakis, N., Ehrlich, S. & Bernardoni, F. Regional gray matter changes in steatotic liver disease provide a neurobiological link to depression: a cross-sectional UK Biobank cohort study. Metabolism 159, 155983 (2024).","journal-title":"Metabolism"},{"key":"1317_CR47","doi-asserted-by":"publisher","first-page":"818","DOI":"10.7150\/ijbs.56214","volume":"17","author":"A Khan","year":"2021","unstructured":"Khan, A. et al. Understanding the effects of gut microbiota dysbiosis on nonalcoholic fatty liver disease and the possible probiotics role: recent updates. Int J. Biol. Sci. 17, 818\u2013833 (2021).","journal-title":"Int J. Biol. Sci."},{"key":"1317_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155952","volume":"158","author":"M Mercado-G\u00f3mez","year":"2024","unstructured":"Mercado-G\u00f3mez, M. et al. The lipopolysaccharide-TLR4 axis regulates hepatic glutaminase 1 expression promoting liver ammonia build-up as steatotic liver disease progresses to steatohepatitis. Metabolism 158, 155952 (2024).","journal-title":"Metabolism"},{"key":"1317_CR49","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S2213-8587(20)30148-0","volume":"8","author":"MB Schulze","year":"2020","unstructured":"Schulze, M. B., Minihane, A. M., Saleh, R. N. M. & Ris\u00e9rus, U. Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases. Lancet Diab. Endocrinol. 8, 915\u2013930 (2020).","journal-title":"Lancet Diab. Endocrinol."}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01317-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01317-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01317-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:04:43Z","timestamp":1769508283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01317-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,27]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1317"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01317-4","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,27]]},"assertion":[{"value":"1 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"59"}}